Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $8.5000 (-4.92%) ($8.4600 - $9.0900) on Tue. Jul. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 16.92% (three month average) | RSI | 35 | Latest Price | $8.5000(-4.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADAP declines -2.5% a day on average for past five trading days. | Weekly Trend | ADAP declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) XBI(23%) SDY(18%) XRT(18%) XME(17%) XLRE(23%) | Factors Impacting ADAP price | ADAP will decline at least -8.46% in a week (0% probabilities). TLT(-12%) VXX(-10%) BNDX(-10%) TIP(-9%) BND(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -8.46% (StdDev 16.92%) | Hourly BBV | 0 () | Intraday Trend | -4.4% | | | |
|
1 - 5 Day Possible Target | $0.17(-98%) | Resistance Level | $9.57 | 5 Day Moving Average | $9.08(-6.39%) | 10 Day Moving Average | $9.41(-9.67%) | 20 Day Moving Average | $9.57(-11.18%) | To recent high | -29.8% | To recent low | 64.4% | Market Cap | $1.314b | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |